BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36304469)

  • 41. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients.
    Baldanti F; Rognoni V; Cascina A; Oggionni T; Tinelli C; Meloni F
    Virol J; 2011 Sep; 8():421. PubMed ID: 21892950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic Detection of Epstein Barr Virus in Pediatric Transplant Recipients From India.
    Janani MK; Malathi J; Rela M; Farouk M; Padmapriya J; Madhavan HN
    Indian Pediatr; 2015 Nov; 52(11):946-50. PubMed ID: 26615341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH; Russ GR; Coates PT
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS; Lemas MV; Ambinder RF
    Transpl Infect Dis; 1999 Sep; 1(3):204-12. PubMed ID: 11428990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J; Li S; Levi M; Weinberg A
    J Clin Virol; 2011 Nov; 52(3):231-5. PubMed ID: 21900040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients.
    Ishihara M; Tanaka E; Sato T; Chikamoto H; Hisano M; Akioka Y; Dohno S; Maeda A; Hattori M; Wakiguchi H; Fujieda M
    Clin Nephrol; 2011 Jul; 76(1):40-8. PubMed ID: 21722604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease.
    Ambinder RF
    Recent Results Cancer Res; 2021; 217():197-207. PubMed ID: 33200367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: A prospective study.
    Verghese PS; Schmeling DO; Filtz EA; Grimm JM; Matas AJ; Balfour HH
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28915342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
    Marques HH; Shikanai-Yasuda MA; dAzevedo LS; Caiaffa-Filho HH; Pierrotti LC; Aquino MZ; Lopes MH; Maluf NZ; Campos SV; Costa SF
    Rev Soc Bras Med Trop; 2014; 47(5):543-6. PubMed ID: 25467252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center.
    Walabh P; Moore DP; Hajinicolaou C
    Transpl Infect Dis; 2024 Apr; 26(2):e14221. PubMed ID: 38152054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Duplex realtime PCR method for Epstein-Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection.
    Fellner MD; Durand K; Rodriguez M; Irazu L; Alonio V; Picconi MA
    Braz J Infect Dis; 2014; 18(3):271-80. PubMed ID: 24389276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children.
    Martinez OM; Krams SM; Robien MA; Lapasaran MG; Arvedson MP; Reitsma A; Balachandran Y; Harris-Arnold A; Weinberg K; Boyd SD; Armstrong B; Trickey A; Twist CJ; Gratzinger D; Tan B; Brown M; Chin C; Desai DM; Fishbein TM; Mazariegos GV; Tekin A; Venick RS; Bernstein D; Esquivel CO
    Am J Transplant; 2023 May; 23(5):611-618. PubMed ID: 36796762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers for PTLD diagnosis and therapies.
    Martinez OM
    Pediatr Nephrol; 2020 Jul; 35(7):1173-1181. PubMed ID: 31240394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD; Hsu DT; Kichuk MR; Garvin JH; Stolar CJ; Haddad J; Stylianos S; Michler RE; Chadburn A; Knowles DM; Addonizio LJ
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder.
    Green M; Michaels MG
    Am J Transplant; 2013 Feb; 13 Suppl 3():41-54; quiz 54. PubMed ID: 23347213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study.
    Parrish A; Fenchel M; Storch GA; Buller R; Mason S; Williams N; Ikle D; Conrad C; Faro A; Goldfarb S; Hayes D; Melicoff-Portillo E; Schecter M; Visner G; Sweet S; Danziger-Isakov L;
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28639398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.